Introduction
============

Acute inflammatory injury incites a cascade of proinflammatory mediators leading to microcirculatory dysfunction, capillary leak, and distributive shock \[[@B1],[@B2]\]. Although in the early stage of shock liberal and goal-directed fluid therapy is mandated \[[@B3]\], subsequent (over)resuscitation increases microvascular hydrostatic pressure and may promote interstitial fluid accumulation \[[@B4]-[@B6]\]. This fluid overload is independently associated with impaired organ function, intra-abdominal hypertension (IAH), and poorer outcome \[[@B7]-[@B15]\]. Conversely, a conservative fluid strategy limiting fluid intake and even promoting fluid removal improved clinical outcomes \[[@B16]\].

As the lungs are maximally exposed to the proinflammatory cascade, receiving the entire cardiac output, they provide valuable insight into dynamic microcirculatory changes during systemic inflammation \[[@B17]\]. Consequently, bedside measurement of extravascular lung water index (EVLWI) performed by single transpulmonary thermodilution allows the estimation of the extent of capillary leak and fluid overload \[[@B11],[@B18]-[@B23]\]. In this study, we investigated the prognostic value of EVLWI, capillary leak parameters, IAH, and fluid balance in critically ill patients.

Methods
=======

Patients
--------

We collected data from March 2004 to August 2007 in 123 patients treated in two ICU\'s in Ziekenhuis Netwerk Antwerpen (ZNA) Campus ZNA Stuivenberg, Antwerp, Belgium. Critically ill patients requiring mechanical ventilation (MV) and, according to clinical appraisal, extended hemodynamic monitoring by single transpulmonary thermodilution technique were consecutively included. Internal review board approval was obtained, and due to the non-interventional and retrospective nature of the study, the need for informed consent was waived (EC approval number 3765).

Definitions
-----------

*Acute lung injury*(*ALI*) and acute respiratory distress syndrome (*ARDS*) were diagnosed according to international criteria \[[@B24]\].

*EVLWI*was recorded as the mean of two daily EVLWI measurements. EVLWI~min,max,mean~were the minimal, maximal, and mean EVLWI during ICU stay, respectively. Maximum EVLWI was measured on Day~max~. Δ~max~EVLWI indicated the maximum difference between all EVLWI measurements during ICU stay and was computed in accordance with overall EVLWI trend (ΔEVLWI or the difference between the first and the last recorded EVLWI). If during ICU stay an increase of EVLWI was recorded followed by an equal EVLWI drop, Δ~max~EVLWI was given the sign of ΔEVLWI. Patients with an EVLWI decrease of \>2 mL/kg (Δ~max~EVLWI \<−2 mL/kg) and an overall drop in EVLWI during the first week of ICU admission (negative ΔEVLWI) were called \'responders\'.

*Intra-abdominal pressure*(*IAP*) was the mean of two daily IAP measurements. IAP~max,mean~were the maximum and the mean IAP during ICU stay. IAH was defined as IAP~mean~≥ 12 mmHg and abdominal perfusion pressure (APP) as mean arterial pressure (MAP) minus IAP according to consensus definitions \[[@B15]\].

Daily *fluid balance*was calculated by subtracting the urinary output from the fluid intake (including both IV and enteral fluid administration); each day cumulative fluid balance was computed by the addition of daily fluid balances.

*Capillary leak index*(*CLI*) was defined as C-reactive protein (CRP) (milligrams per deciliter) over albumin (grams per liter) ratio, multiplied by 100 \[[@B25]\].

*Conservative late fluid management*(*CLFM*) was determined as even-to-negative fluid balance on at least two consecutive days during the first week of ICU stay \[[@B12]\]. In this study, CLFM was used as a descriptive term and did not signify any study intervention.

Data collection and methods
---------------------------

For the entire duration of the ICU stay, relevant demographic, clinical, and laboratory data along with daily assessment of fluid balance, sequential organ failure assessment (SOFA) score \[[@B26]\], IAP, MV settings, and extended hemodynamic monitoring variables were registered in an electronic database, supplemented by mortality on day 28. Severity of illness on ICU admission was described by an averaged simplified acute physiology score \[[@B27]\] and acute physiology and chronic health evaluation score \[[@B28]\].

IAP was measured via a Foley bladder catheter as described previously \[[@B29]\], in the complete supine position and in stable conditions twice daily. In patients with IAH, the IAP was also continuously monitored via a balloon-tipped catheter placed in the stomach connected to the CiMON monitor (Pulsion Medical Systems, Munich, Germany).

A central venous catheter and a thermistor-tipped arterial thermodilution catheter (Pulsiocath 5F) inserted into the femoral artery and attached to a PiCCOplus^®^system (Pulsion Medical Systems, Munich, Germany) were already in place for each patient. Transpulmonary thermodilution measurements were obtained by central venous injection of three 20-mL boluses of cooled saline (\<8°C). For each set of thermodilution determinations, the mean values were used for statistical analysis. Cardiac output (CO), global end diastolic volume (GEDV), extravascular lung water (EVLW), global ejection fraction (GEF), pulmonary vascular permeability index (PVPI), stroke volume variation, and pulse pressure variation were calculated using the PiCCOplus^®^\[[@B18]\]. EVLW was indexed to body weight (EVLWI) and CO and GEDV to body surface area (cardiac index, GEDV index).

Study design
------------

In this observational study, no protocol-directed intervention was performed; treatment was based on recent ICU guidelines. We analyzed process-of-care variables for the first 7 days of ICU admission. The primary outcome parameter was 28-day mortality. Secondary outcome parameters were organ dysfunction, duration of MV, and achievement of CLFM.

Statistical analysis
--------------------

The primary data analysis compared survivors to nonsurvivors according to 28-day mortality. Subsequently, patients were stratified by occurrence of IAH, achievement of CLFM, and responders vs nonresponders.

Continuous data were expressed by mean ± SD, and intergroup differences were determined by one-way analysis of variance (ANOVA) analyses day by day for 1 week. Categorical data were expressed as frequency distributions and/or percentages, and the *χ*^2^test was used to determine intergroup differences. Two-sided *p*values \<0.05 were considered to indicate statistical significance.

Time course of CLI, total SOFA score, EVLWI, APP, daily, and cumulative fluid balance was described by clustered error bar graphs representing mean ± SE. Receiver-operating characteristic (ROC) curves were determined and optimal cutoffs for CLI, EVLWI, and Δ~max~EVLWI were derived, creating categorical data.

Stepwise multivariate logistic regression was performed to determine the independent risk factors for 28-day mortality and for not achieving CLFM. Risk factors significant at the 0.1 level in univariate analysis were included in the models. The Hosmer-Lemeshow test was used assessing the goodness of fit.

The Kaplan-Meier method was used to analyze differences in cumulative survival and duration of MV; distribution was compared using the log-rank test. We used SPSS software package (version 17.0.1; SPSS, Chicago, IL, USA) for data analysis.

Results
=======

Patients
--------

We included 123 predominantly medical (*n*= 109) patients on MV, of whom 65 (53%) died after 28 days. At baseline, no significant differences were found between groups, as shown in Table [1](#T1){ref-type="table"}, except for lower MAP and GEF in nonsurvivors.

###### 

Baseline characteristics

  Variable                              Survivors (*n*= 58)   Nonsurvivors (*n*= 65)   *p*value
  ------------------------------------- --------------------- ------------------------ ----------
  Age (years)                           63.2 ± 14.2           65.3 ± 15.2              0.436
                                                                                       
  Male sex (%)                          66                    67                       0.798
                                                                                       
  BMI (kg/m2)                           26.6 ± 6.6            24.6 ± 4.0               0.053
                                                                                       
  Primary reason for MV (%)                                                            0.937
   Sepsis/septic shock                  24.1                  24.7                     
   Pneumonia                            15.5                  16.9                     
   ARDS                                 13.7                  10.8                     
   Postoperative/trauma                 5.4                   6.1                      
   Acute COPD exacerbation              6.9                   7.7                      
   Congestive heart failure             6.9                   6.2                      
   Cardiac arrest                       5.2                   6.2                      
   Hemorrhagic stroke                   8.6                   7.6                      
   Other                                13.7                  13.8                     
                                                                                       
  Medical ICU (%)                       40.7                  48.0                     0.562
                                                                                       
  ICU stay (day)                        31.8 ± 18.1           11.0 ± 6.4               \<0.001
                                                                                       
  Severity of disease                                                                  
   SAPS II                              49.5 ± 15.6           53.9 ± 18.1              0.157
   APACHE II                            22.1 ± 8.5            23.0 ± 10.7              0.617
   SOFA score at admission              10.3 ± 4.3            10.4 ± 4.5               0.844
                                                                                       
  Acute lung injury (%)                                                                0.836
   Primary                              27.5                  30.7                     
   Secondary                            25.8                  21.5                     
                                                                                       
  Organ function assessment                                                            
   Number of organs failing             2.2 ± 1.3             2.1 ± 1.2                0.605
                                                                                       
  Hemodynamic variables                                                                
   HR (bpm)                             96.7 ± 20.4           98.6 ± 18.8              0.661
   Mean arterial pressure (mmHg)        84.2 ± 13.4           78.7 ± 10.4              0.011
   Met shock criteria (%)               69.0                  69.2                     0.975
   Vasopressor use (%)                  69.0                  67.8                     0.880
   CI (L/min/m^2^)                      3.6 ± 1.1             3.1 ± 1.6                0.255
   SVV (%)                              11.8 ± 7.1            14.4 ± 6.9               0.236
   GEF (%)                              21.2 ± 8.1            15.1 ± 7.7               0.015
   GEDVI (mL/m^2^)                      766.2 ± 165.0         725.6 ± 174.5            0.42
   EVLWI (mL/kg)                        9.8 ± 3.9             10.5 ± 5.2               0.543
   PVPI                                 2.4 ± 0.9             2.4 ± 1.1                0.869
                                                                                       
  Respiratory variables                                                                
   Tidal volume (mL/kg of PBW)          8.2 ± 1.7             8.3 ± 1.7                0.709
   Plateau pressure (cmH~2~O)           23.8 ± 6.5            24.1 ± 8.2               0.792
   PEEP (cmH~2~O)                       7.0 ± 2.2             6.2 ± 2.3                0.075
   Dynamic compliance (mL/cmH~2~O)      40.9 ± 15.6           39.0 ± 22.6              0.635
   PaO~2~/FIO~2~                        263.4 ± 135.1         271.7 ± 154.9            0.755
                                                                                       
  Renal and metabolic variables                                                        
   Creatinine (mg/dL)                   1.8 ± 1.7             2.5 ± 2.9                0.095
   Urine output (mL/day)                1,524.6 ± 1,342.7     1,428.5 ± 1,236.6        0.683
   Albumin (mg/dL)                      25.0 ± 7.5            27.0 ± 8.7               0.194
   pH                                   7.35 ± 0.11           7.32 ± 0.12              0.205
                                                                                       
  Immune system                                                                        
   CRP (mg/dL)                          10.6 ± 9.8            13.8 ± 12.4              0.127
   Central nervous system                                                              
   Glasgow Coma Score                   8.1 ± 5.1             8.2 ± 5.2                0.905
                                                                                       
  Capillary leak index                  52.7 ± 56.2           61.8 ± 61.3              0.411
                                                                                       
  Intra-abdominal pressure (mmHg)       8.2 ± 3.5             7.9 ± 3.7                0.722
                                                                                       
  Abdominal perfusion pressure (mmHg)   75.4 ± 13.9           70.4 ± 11.3              0.071
                                                                                       
  Fluid balance (mL/day)                1,755.9 ± 4,616.0     2,133.8 ± 3,525.1        0.612

BMI, body mass index; MV, mechanical ventilation; ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; SAPS, simplified acute physiology score; APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment; HR, heart rate; CI, cardiac index; SVV, stroke volume variation; GEF, global ejection fraction; GEDVI, global end-diastolic volume index; EVLWI, extravascular lung water index; PVPI, pulmonary vascular permeability index; PBW, predicted body weight; PEEP, positive end-expiratory pressure; CRP, C-reactive protein.

Process-of-care variables
-------------------------

Figure [1](#F1){ref-type="fig"} depicts process-of-care variables stratifying patients by survival.

![**Time course of main variables**. Mean ± standard error of pertinent variables for the first week after ICU admission. Survivors are depicted by a full line and nonsurvivors by a dotted line. \**p*\< 0.05, day-by-day pairwise compared between survivors and nonsurvivors (one-way ANOVA).](2110-5820-2-S1-S1-1){#F1}

### CLI

CLI had a biphasic course with a maximum on day 3, which was significantly higher in patients not achieving CLFM (76.1 ± 49.6 vs 53.2 ± 45.6, *p*= 0.017). ROC statistics for CLI on day 3 to predict no CLFM achievement revealed an area under the curve (AUC) of 0.658 and a derived cutoff point of \>61 (sensitivity 62%, specificity 68%, and positive predictive value (PPV) 80%).

### EVLWI

EVLWI measurements are outlined in Table [2](#T2){ref-type="table"}. ROC statistics using baseline EVLWI, EVLWI~max~, and EVLWI~mean~to predict outcome revealed an AUC of 0.513, 0.591, and 0.595, respectively. The best predictor for mortality was EVLWI~max~with a cutoff point of \>11 mL/kg, showing a 60% sensitivity and a 57% specificity with a PPV of 61%. EVLWI~max~\>11 mL/kg was correlated with a higher percentage of ALI (70% vs 34%, *p*\< 0.001), higher tidal volumes (8.8 ± 1.9 vs 7.8 ± 1.4 mL/kg, *p*= 0.001), and a trend to higher mortality (61% vs 44%, *p*= 0.061). Δ~max~EVLWI was significantly lower if CLFM was achieved (−2.4 ± 4.8 vs 1.0 ± 5.5 mL/kg, *p*= 0.001) and in survivors (Table [2](#T2){ref-type="table"}). The AUC for Δ~max~EVLWI to predict survival was 0.822. The best cutoff point for Δ~max~EVLWI predicting good outcome was \<−2 mL/kg showing a sensitivity of 74% and a specificity of 78% with a PPV of 75% (Figure [2](#F2){ref-type="fig"}).

###### 

Analysis of EVLWI

  Variable              Survivors (*n*= 58)   Nonsurvivors (*n*= 65)   *p*value
  --------------------- --------------------- ------------------------ ----------
  EVLWI~min~(mL/kg)     7.3 ± 2.7             8.5 ± 4.1                0.059
  EVLWI~max~(mL/kg)     11.7 ± 4.3            13.7 ± 5.9               0.041
  EVLWI~mean~(mL/kg)    9.2 ± 3.3             10.7 ± 4.6               0.043
  Day EVLWI~max~(day)   2.4 ± 1.4             3.1 ± 2.2                0.026
  ΔEVLWI (mL/kg)        −1.3 ± 3.5            2.1 ± 5.0                \<0.001
  Δ~max~EVLWI (mL/kg)   −3.3 ± 3.8            2.5 ± 5.3                \<0.001

EVLWI~min~, minimal EVLWI during ICU stay; EVLWI~max~, maximal EVLWI during ICU stay; EVLWI~mean~, mean EVLWI during ICU stay; ΔEVLWI, difference between first and last extravascular lung water index; Δ~max~EVLWI, maximal difference between extravascular lung water index.

![**Receiver-operating characteristic (ROC) curve**. Sensitivity and specificity of Δ~max~EVLWI with respect to 28-day mortality according to ROC analysis in 123 patients. The Area under the curve (AUC) was 0.822.](2110-5820-2-S1-S1-2){#F2}

### IAP measurements

IAP~mean~was lower if CLFM was achieved (8.1 ± 2.6 vs 9.6 ± 3.0 mmHg, *p*= 0.013) and APP on day 3 was significantly higher in survivors (80.7 ± 10.7 vs 70.9 ± 13.5 mmHg, *p*\< 0.001). IAH occurred in 25 patients (20%) and was not correlated with 28-day mortality (*p*= 0.658), CLFM achievement (*p*= 0.150), or whether patients were responders or not (*p*= 0.822). Pertinent variables recorded 1 week after ICU admission in the remaining 85 patients are summarized in Table [3](#T3){ref-type="table"}.

###### 

Analysis by IAH

  Variable (1 week after ICU admission)   No IAH (*n*= 64)   IAH (*n*= 21)    *p*value
  --------------------------------------- ------------------ ---------------- ----------
  SOFA score                                                                  
   Respiratory                            1.5 ± 1.5          1.7 ± 1.8        0.374
   Nervous                                2.4 ± 1.6          3.5 ± 1.0        0.004
   Cardiovascular                         2.0 ± 1.6          2.7 ± 1.3        0.092
   Liver                                  0.6 ± 1.0          1.2 ± 1.4        0.038
   Coagulation                            0.8 ± 1.1          1.3 ± 1.1        0.084
   Renal                                  1.1 ± 1.5          2.4 ± 1.8        0.002
   Total                                  8.3 ± 4.9          12.8 ± 4.9       0.001
                                                                              
  Respiratory variables                                                       
   Tidal volume (mL/kg of PBW)            8.9 ± 2            8.4 ± 2.3        0.343
   Plateau pressure (cmH~2~O)             24.4 ± 6.9         29.1 ± 6         0.010
   PEEP (cmH~2~O)                         7.3 ± 2.9          10.2 ± 3.7       0.001
   Dynamic compliance (mL/cmH~2~O)        43.9 ± 24.2        38.4 ± 13        0.353
   PaO~2~/FIO~2~                          275.7 ± 98.4       257.8 ± 106.2    0.486
                                                                              
  Ventilator-free days                    2.1 ± 2.1          1.4 ± 2.1        0.479
                                                                              
  Cumulative fluid balance (mL)           5,943 ± 7,125      10,176 ± 7,523   0.024
                                                                              
  EVLWI (mL/kg)                           9.8 ± 4.3          9.2 ± 3.7        0.592

IAH, intra-abdominal hypertension; SOFA, sequential organ failure assessment; PBW, predicted body weight; PEEP, positive end-expiratory pressure; EVLWI, extravascular lung water index.

### Cumulative fluid balance

Cumulative fluid balance after 1 week was significantly lower in survivors (4,970 ± 7,737 vs 9,502 ± 6,909 mL, *p*= 0.008), patients achieving CLFM (1,056 ± 7,047 vs 10,282 ± 5,788 mL, *p*\< 0.001), and responders (3,567 ± 7,984 vs 10,021 ± 5,920 mL, *p*\< 0.001) as shown in Figure [3](#F3){ref-type="fig"}.

![**Evolution of cumulative fluid balance in (non)responders**. Mean ± standard error cumulative fluid balance for the first week after ICU admission. Responders are depicted by a full line and nonresponders by a dotted line. \**p*\< 0.05, day-by-day pairwise compared between responders and nonresponders (one-way ANOVA).](2110-5820-2-S1-S1-3){#F3}

### Total SOFA score

Total SOFA score remained significantly lower on each day from day 2 in survivors, patients achieving CLFM, and responders (*p*\< 0.001).

Clinical outcomes
-----------------

Outcomes concerning organ function were described by the course of total SOFA score as above. Other major outcomes are shown in Table [4](#T4){ref-type="table"} and Kaplan-Meier plots are shown in Figure [4](#F4){ref-type="fig"}.

###### 

Major outcome variables

                                                             Responder (*n*= 52)   Nonresponder (*n*= 71)   *p*value
  --------------- ------------------------- ---------------- --------------------- ------------------------ ----------
  First week      Organ-failure-free days   Respiratory      5.5 ± 1.9             3.9 ± 2.4                \<0.001
                                            Nervous          2.1 ± 2.6             1.7 ± 2.2                0.454
                                            Cardiovascular   3.4 ± 2.7             1.4 ± 2.1                \<0.001
                                            Liver            6.1 ± 1.9             5.3 ± 2.3                0.046
                                            Coagulation      5.9 ± 2.1             5.0 ± 2.4                0.031
                                            Renal            4.8 ± 2.7             3.9 ± 2.7                0.063
                                                                                                            
                  Ventilator-free days                       2.5 ± 2.3             1.5 ± 2.3                0.023
                                                                                                            
  First 28 days   Death (%)                                  25.0                  73.2                     \<0.001

![**Kaplan-Meier plots**. Kaplan-Meier plots for cumulative survival and proportion of patients on MV. We compared CLFM and no CLFM achievement (full lines and dotted lines, respectively) in A (survival) and B (ventilation). In C (survival) and D (ventilation), responders and nonresponders were compared (full lines and dotted lines, respectively).](2110-5820-2-S1-S1-4){#F4}

Mortality and duration of MV were lower in patients achieving CLFM and in responders. Responders had fewer days with cardiovascular, respiratory, liver, and coagulation failure during the first week of ICU admission.

Multivariate analysis identified that increasing IAP~mean~and CLI on day 3 and being a nonresponder were independent risk factors for not achieving CLFM (*p*= 0.919 Hosmer-Lemeshow test) (Table [5](#T5){ref-type="table"}). Increasing baseline creatinine and EVLWI~max~, decreasing APP on day 3, not achieving CLFM, and being a nonresponder were independent risk factors for 28-day mortality (*p*= 0.808 Hosmer-Lemeshow test) (Table [6](#T6){ref-type="table"}).

###### 

Multivariate analysis of independent risk factors for not achieving CLFM

                 Variable           Adjusted OR   95% CI       *p*value
  -------------- ------------------ ------------- ------------ ----------
  **Baseline**   Age (years)        1.00          0.97-1.03    0.832
                 BMI (kg/m^2^)      0.93          0.85-1.01    0.073
                                                               
  **Day 3**      Total SOFA score   1.03          0.92-1.16    0.575
                 CLI \>61           2.76          1.02-7.48    0.046
                                                               
  **ICU stay**   IAP~mean~(mmHg)    1.28          1.06-1.54    0.011
                 Nonresponder       5.52          2.01-15.15   0.001

OR, odds ratio; CI, confidence interval; BMI, body mass index; CLI, capillary leak index; IAP, intra-abdominal pressure.

###### 

Multivariate analysis of independent risk factors for 28-day mortality

                 Variable               Adjusted OR   95% CI       *p*value
  -------------- ---------------------- ------------- ------------ ----------
  **Baseline**   Age (years)            1.01          0.96-1.05    0.801
                 BMI (kg/m^2^)          0.92          0.83-1.03    0.142
                 Creatinine (mg/dL)     1.89          1.03-3.48    0.041
                                                                   
  **Day 3**      APP (per −10 mmHg)     2.20          1.25-3.89    0.007
                 Total SOFA score       1.01          0.89-1.15    0.852
                                                                   
  **ICU stay**   EVLWI~max~\>11 mL/kg   4.57          1.32-15.63   0.016
                 CLFM not achieved      9.34          2.39-36.93   0.001
                 Nonresponder           7.14          2.23-22.91   0.001

OR, odds ratio; CI, confidence interval; BMI, body mass index; APP, abdominal perfusion pressure; SOFA, sequential organ failure assessment; EVLWI~max~, maximal EVLWI during ICU stay; CLFM, conservative late fluid management.

Discussion
==========

Our study demonstrated that a persistent increase in CLI, EVLWI, and fluid balance in critically ill patients is associated with poor outcome. We investigated the precise prognostic value of these parameters and were able to formulate a unifying hypothesis implementing concepts of earlier studies (Figure [5](#F5){ref-type="fig"}).

![**Proposed time course in shock, introducing a three-hit model and global increased permeability syndrome**.](2110-5820-2-S1-S1-5){#F5}

As early as 1942, Cuthbertson introduced the concept of a dual metabolic response to bodily injury \[[@B30]\]. In direct response to initial proinflammatory cytokines and stress hormones, the ebb phase represents a distributive shock characterized by arterial vasodilatation and transcapillary albumin leak \[[@B31]\] abating plasma oncotic pressure. Arterial underfilling, microcirculatory dysfunction, and secondary interstitial edema lead to systemic hypoperfusion and impaired regional tissue oxygenation \[[@B2]\]. In this early stage of shock, adequate fluid therapy comprises of goal-directed filling \[[@B3]\] to prevent evolution to multiple organ dysfunction syndrome (MODS). As compensatory neuroendocrine reflexes and potential renal dysfunction result in sodium and water retention \[[@B32]\], positive fluid balances are inherent in the ebb phase. Patients with higher severity of illness need more fluids to achieve cardiovascular optimization. Therefore, at this point, fluid balance may be considered a biomarker of critical illness \[[@B33]\].

Patients overcoming shock attain homeostasis inflammatory mediators within 3 days \[[@B1]\]. Subsequent hemodynamic stabilization and restoration of plasma oncotic pressure set off the flow phase with resumption of diuresis and mobilization of extravascular fluid resulting in negative fluid balances. In line with Murphy et al. \[[@B12]\], we found CLFM achievement to be a strong and independent predictor of survival. In contrast, patients with persistent systemic inflammation maintain capillary leak and do not reach the flow phase, accumulating further positive fluid balances. In this context, we introduce the global increased permeability syndrome (GIPS), characterized by nonresponders with increased CLI, no CLFM achievement, and progressing organ failure. GIPS represents a \'third hit\' of shock following acute injury and MODS.

We defined CLI as a parameter of capillary leak, assuming that increased vascular permeability caused by systemic inflammation is associated with high CRP levels \[[@B34]\] and hypoalbuminemia \[[@B31]\]. CLI had a biphasic course and the maximum reached on the third day of shock was an independent predictor of CLFM achievement. Previously, a negative cumulative balance \[[@B8],[@B12],[@B13],[@B35],[@B36]\] and lower PVPI \[[@B22]\] on day 3 were correlated with better survival. The third day of shock seems to be a crucial turning point \[[@B37]\] at which homeostasis of cytokines is accompanied by the healing of microcirculatory disruptions and \'closure\' of the capillary leak. This interpretation is supported by Boerma et al. who demonstrated normalization of the microcirculatory blood flow on day 3 in septic patients \[[@B38]\].

As a result of capillary leak and an impaired flow phase, overzealous administration of fluids in GIPS will lead to gross fluid overload and tissue edema \[[@B14]\]. Interstitial edema raises the pressure in all four major body compartments: head, chest, abdomen, and extremities. Consequently, venous resistance of organs within compartments increases and perfusion pressure decreases contributing to progression of organ failure. As different compartments interact and reciprocally transmit compartment pressures, the concept of polycompartment syndrome is suggested \[[@B39]\].

The abdomen plays a central role in GIPS and polycompartment syndrome. Positive cumulative fluid balance is a known risk factor for secondary IAH \[[@B40]\] which in turn is associated with renal dysfunction \[[@B41]\]. Therefore, fluid overload leading to IAH and renal dysfunction may counteract its own resolution. Data from our study support these ideas, demonstrating higher average positive cumulative fluid balance and renal SOFA score after 1 week in patients developing IAH. Moreover, we determined increased IAP~mean~as an independent risk factor for no CLFM achievement and decreased APP as risk factor for 28-day mortality.

As the adverse effects of fluid overload in states of capillary leak are particularly pronounced in the lungs \[[@B17]\], monitoring EVLWI may offer a valuable tool to guide fluid management in the critically ill. In line with previous reports, we established a correlation between EVLWI~max~during admission and poor outcome \[[@B42]\]. An increased EVLWI~max~may indicate a state of capillary leak, associated with a higher severity of illness and mortality \[[@B11],[@B22],[@B23],[@B42]\]. In this context, data from Sturm et al. are particularly of interest, correlating EVLWI with albumin extravasation in patients after multiple trauma \[[@B43]\].

The course of EVLWI during the first week of admission may even be a better outcome predictor. Responders, defined as patients with an EVLWI decrease of \>2 mL/kg, were more likely to achieve CLFM, had more organ-failure-free and ventilator-free days, and a better 28-day outcome. These data suggest that responders overcome the distributive shock and make a transition to the flow phase. Nonresponders on the other hand stay in the grip of the ebb phase and progress to GIPS associated with interstitial fluid accumulation, organ failure, and death. In this hypothesis, (the change in) EVLWI has a prognostic value as a reflection of the extent of capillary leak rather than as a quantification of lung function impairment. Indeed, the degree of hypoxemia in ARDS is an inferior prognostic factor, as extrapulmonary organ failure mostly determines outcome \[[@B44]\]. Accordingly, in a subgroup analysis of patients with ARDS, Sakka et al. found no higher maximum EVLWI in nonsurvivors \[[@B42]\]. Therefore, in an established state of capillary leak, time-dependent changes in EVLWI appear to be of superior value.

Our observations may have direct consequences on fluid management in the critically ill. Patients at risk for GIPS require restrictive fluid strategies and even fluid removal to avoid interstitial edema formation.

Our study has several important limitations. First, the observational nature of this study does not allow discrimination between a primary and secondary effect of fluid balance on outcome; prospective trials are warranted to determine if fluid overload is cause or consequence of worse outcome. Second, inclusion of patients was based on clinical appraisal of the need of MV and thermodilution catheter monitoring. Therefore, the studied population was a specific case mix of seriously ill patients selected without well-defined objective rules making simple extrapolation of our results to a general ICU population impossible. However, albeit in this particular population, our observations contributed to some basic ideas regarding fluid management in patients with capillary leak as proposed in earlier reports \[[@B1],[@B14],[@B16],[@B37],[@B40]\] and raised questions that should be addressed in future prospective investigations. Third, our database did not supply detailed information on the amounts of fluids administrated specified for the first 6 h. Early fluid resuscitation has an important impact on outcome \[[@B12],[@B45]\]. There were no data on the type of fluids and infusion rates used during ICU stay either. Fourth, differences in MAP and GEF at baseline may be important confounding factors as they may reflect different hemodynamic states dictating whether a patient can mobilize fluids in the flow phase.

Conclusions
===========

We identified a subgroup of mechanically ventilated patients with persistent capillary leak failing to reach the flow phase. In these patients, GIPS may reflect a \'third hit\' and superfluous fluid administration may be considered toxic. Future prospective clinical trials evaluating any therapy aimed at a reduction of EVLWI are warranted.
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